Novavax (NVAX) Initiates Phase 2b/3 Hummingbird Trial for COVID-19 Vaccine in Children Aged Six Months Through 11 Years

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. USO
2. SPY
3. TTAN
4. IONQ
5. QCOM
6. IONS
7. ROIV
8. ORCL
9. AAPL
10. HOOD

Go back to Novavax (NVAX) Initiates Phase 2b/3 Hummingbird Trial for COVID-19 Vaccine in Children Aged Six Months Through 11 Years
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.19 --0 (-0%)
Previous Close $10.19    52 Week High $9.23 
Open $10.19    52 Week Low $1.16 
Day High $10.19    P/E N/A 
Day Low $10.19    EPS $-0.30 
Volume 2,745